Aventis promotes improved Dr. Chart program, MyDocOline software

Arnold, Matthew
May 2003
Medical Marketing & Media;May2003, Vol. 38 Issue 5, p30
Trade Publication
Reports on Aventis Inc.'s upgrade of its MyDocOnline software suite with the launch of Practice Solutions software. Automation of billing and prescribing functions; Expansion of the Dr. Chart program; Efforts to improve patient compliance.


Related Articles

  • Sanofi taps Median image analysis software for lung cancer trial. Sheridan, Cormac // Medical Device Daily;2/2/2012, Vol. 16 Issue 22, p1 

    This article reports on the selection of the Median LMS imaging software from Median Technologies by Sanofi for a phase II study of an investigational drug in small cell lung cancer. Under an agreement, Median will deploy the software to provide Sanofi with standardized computed tomography (CT)...

  • Sanofi-Aventis, Cegedim join forces. A. V. // Medical Marketing & Media;Jul2009, Vol. 44 Issue 7, p12 

    The article reports that Cegedim Dendrite has signed a three-year agreement with Sanofi-Aventis SA in order to provide Mobile Intelligence Customer Relationship Management (CRM) solution to users across several countries. The solution has been deployed for users in the U.S., France and Spain....

  • APPLICATIONS: IN BRIEF.  // Scientific Computing World;Apr/May2008, Issue 99, p6 

    The article offers world news briefs related to the computer software industry. Watson Laboratory Information Management System (LIMS ) from Thermo Fisher Scientific Inc. has been selected by PRA International to help supervise its Bioanalytical Laboratory. Sanofi-Aventis has purchased a suite...

  • ETHYPHARM TO DEVELOP A FLASH VERSION OF AVENTIS' ALLEGRA.  // Worldwide Biotech;Jul2002, Vol. 14 Issue 7, p6 

    Reports on a licensing agreement signed by Ethypharm with Aventis.

  • Aventis contributes $1 million to Red Cross.  // Pest Control;Feb2002, Vol. 70 Issue 2, p60 

    Reports the assistance of Aventis to the American Red Cross for the ongoing relief efforts following the terrorist attacks in Montvale, New Jersey.

  • Sanofi: Time not right to sell off beauty unit.  // WWD: Women's Wear Daily;9/8/1997, Vol. 174 Issue 48, p4 

    Focuses on pharmaceuticals and beauty products company, Sanofi's executive vice president for administration and finance, Jean-Paul Leon's issuance of a statement to clarify French business newspapers report that the company is planning to sell off its beauty division. Overview on Sanofi's...

  • Retork completes system upgrade at Aventis plant.  // Life Science Today;Jun2000, Vol. 1 Issue 3, p2 

    Focuses on the completion of the end control system project by Rotork Control and Safety at the Aventis research facility. Expansion of the pilot-scale control system; Importance of Good Automated Manufacturing Practice guidelines for the ownership of the project; Start-up problems of the project.

  • Aventis Streamlines R&D. Houlton, Sarah // Pharmaceutical Executive;Sep2002, Vol. 22 Issue 9, p21 

    Reports on Aventis' plan to reduce its research and development costs by spinning out a stake in one of its research units. Plans of the private equity house Warburg Pincus to invest in ProSkelia; Aventis' plan to spin off its gene therapy unit, Gencell.

  • Beauty sales at Sanofi decline 2%.  // WWD: Women's Wear Daily;4/14/1995, Vol. 169 Issue 72, p9 

    Reports on the decline in sales of Sanofi SA's beauty products and fragrances during the first quarter of 1995.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics